Literature DB >> 11173917

Helicobacter pylori infection increases mucosal permeability of the stomach and intestine.

Y Fukuda1, H Bamba, M Okui, K Tamura, N Tanida, M Satomi, T Shimoyama, T Nishigami.   

Abstract

It is important to study the effect of Helicobacter pylori infection on the permeability of the intestine. Permeability was evaluated by oral sucrose tolerance test using sucrose 25 g in 200 ml of water. Existence of H. pylori itself was associated with increased permeability of sucrose. Also, the permeability of sucrose increased as polymorphonuclear and lymphocyte infiltration increased. The increase of mucosal permeability suggests that antigens like protein penetrate into the body and result in systemic reactions. Thus, it is important to study the implication of increased permeability in relation not only to gastric diseases but also certain systemic diseases. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173917     DOI: 10.1159/000051918

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  25 in total

1.  Significance of a novel sucrose permeability test using serum in the diagnosis of early gastric cancer.

Authors:  Tadayuki Shishido; Taketo Yamaguchi; Takeo Odaka; Masanori Seimiya; Hiromitsu Saisho; Fumio Nomura
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 2.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

3.  Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test.

Authors:  Edoardo G Giannini; Federica Malfatti; Federica Botta; Simone Polegato; Emanuela Testa; Alessandra Fumagalli; Mario Mamone; Vincenzo Savarino; Roberto Testa
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

4.  Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.

Authors:  Yoshio Sumida; Kazuyuki Kanemasa; Shunsuke Imai; Kojiro Mori; Saiyu Tanaka; Hideto Shimokobe; Yoko Kitamura; Kohei Fukumoto; Akira Kakutani; Tomoyuki Ohno; Hiroyoshi Taketani; Yuya Seko; Hiroshi Ishiba; Tasuku Hara; Akira Okajima; Kanji Yamaguchi; Michihisa Moriguchi; Hironori Mitsuyoshi; Kohichiroh Yasui; Masahito Minami; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2015-01-28       Impact factor: 7.527

Review 5.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 6.  Parkinson's disease: Are gut microbes involved?

Authors:  Yogesh Bhattarai; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

Review 7.  Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier.

Authors:  Tyler J Caron; Kathleen E Scott; James G Fox; Susan J Hagen
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 8.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 9.  Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.

Authors:  F Lirussi; E Mastropasqua; S Orando; R Orlando
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

10.  Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.

Authors:  Christian S Alvarez; Andrea A Florio; Julia Butt; Alvaro Rivera-Andrade; María F Kroker-Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D Freedman; Barry I Graubard; Mariana Lazo; Eliseo Guallar; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  Helicobacter       Date:  2020-10-02       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.